Vivendi (VIV) Given a €34.00 Price Target by Deutsche Bank Analysts

Vivendi (EPA:VIV) has been assigned a €34.00 ($39.53) price objective by stock analysts at Deutsche Bank in a research note issued on Tuesday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock.

VIV has been the subject of a number of other reports. Jefferies Financial Group set a €22.00 ($25.58) price objective on shares of Vivendi and gave the stock a “neutral” rating in a research report on Friday, February 15th. Credit Suisse Group set a €25.40 ($29.53) price objective on shares of Vivendi and gave the stock a “buy” rating in a research report on Monday, February 18th. Barclays set a €25.50 ($29.65) price objective on shares of Vivendi and gave the stock a “neutral” rating in a research report on Tuesday. UBS Group set a €29.00 ($33.72) price objective on shares of Vivendi and gave the stock a “buy” rating in a research report on Tuesday. Finally, HSBC set a €24.50 ($28.49) price objective on shares of Vivendi and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Vivendi presently has an average rating of “Buy” and a consensus price target of €26.58 ($30.91).

Vivendi has a 12-month low of €16.85 ($19.59) and a 12-month high of €24.87 ($28.92).

About Vivendi

Vivendi SA operates as a content media and communication company in France, rest of Europe, the Americas, Asia/Oceania, and Africa. It operates through Universal Music Group, Canal+ Group, Havas, Gameloft, Vivendi Village, and New Initiatives segments. The Universal Music Group segment engages in the sale of digital and physical recorded music; and exploitation of music publishing rights, as well as provision of artist and merchandising services.

Featured Article: Commodities

Analyst Recommendations for Vivendi (EPA:VIV)

Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.